RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.57
−4.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.78x
- Price / sales
- 12.08x
- Price / cash flow
- -0.36x
Enterprise value
- Enterprise value
- $803.8K
- EV / sales
- 2.81x
- EV / EBITDA
- -0.11x
- EV / EBIT
- -0.10x
- Market cap
- $3.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025